-
Company Profile
Xenon Pharmaceuticals Inc – Company Profile
Xenon Pharmaceuticals Inc (Xenon) is a clinical-stage biopharmaceutical company that develops innovative therapeutics for neurological disorders. The company’s pipeline products include XEN1101, NBI-921352, and XEN496. XEN1101 is a differentiated Kv7 potassium channel opener under development to treat focal onset seizures, major depressive disorder and primary generalized tonic-clonic seizures. NBI-921352 and XEN496 are under development for treating focal-onset seizures in adults, pediatric epilepsy and orphan pediatric epilepsy. The company collaborates with other pharmaceutical companies for the development of therapeutic drug candidates....
Add to Basket -
Company Profile
Ra Medical Systems Inc – Company Profile
Catheter Precision Inc (Catheter Precision), formerly Ra Medical Systems Inc, is a medical device company that develops, commercializes, and markets its advanced excimer laser-based technology to treat vascular and dermatological immune-mediated inflammatory illnesses. The company’s product portfolio includes VIVO System, LockeT and Amigo Remote Catheter System. View into Ventricular Onset technology or VIVO System, is a non-invasive imaging technology that provides 3D cardiac mapping to assist in locating the locations of origin of idiopathic ventricular arrhythmias in patients with structurally...
Add to Basket -
Company Profile
Lantheus Holdings Inc – Company Profile
Lantheus Holdings Inc (Lantheus) carries out the development, manufacturing, sale and distribution of diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The company offers products such as DEFINITY, VIALMIX, TechneLite, Xenon-133, NEUROLITE, Cardiolite, Gallium-68, and ABLAVAR. It offers its products in the therapeutic area of oncology, urology, nuclear medicine, cardiology, sonography and radiology among others. The company serves to hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacy, clinics...
Add to Basket -
Company Profile
Air Products and Chemicals Inc – Company Profile
Air Products and Chemicals Inc (Air Products) is a provider of industrial gases. Its portfolio of products includes atmospheric, process and specialty gases and related equipment. The company supplies argon, carbon dioxide, neon, xenon, krypton, carbon monoxide, syngas, helium, hydrogen, nitrogen, oxygen, specialty gases, gas mixtures and welding gases. Air Products caters to electronics, chemicals, metals, manufacturing, and food and beverage markets. It operates through a network of production facilities and industrial gas pipelines. The company has a presence in...
Add to Basket -
Company Profile
Lantheus Medical Imaging Inc – Company Profile
Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures and commercializes diagnostic imaging agents and products. The company offers commercial products including ultrasound contrast agent and medical radiopharmaceuticals in a range of imaging modalities. Its products include DEFINITY, TechneLite, Xenon 133, Neurolite, , Thallium-201, Cardiolite and Gallium-67. The company’s product pipeline include 1095 and LMI 1195. The company offers its products to nuclear physicians, internal medicine physicians, radiologists, technologists and sonographers, integrated delivery networks, hospitals,...
Add to Basket -
Product Insights
Lantheus Medical Imaging Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Lantheus Medical Imaging Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures and commercializes diagnostic imaging agents and products. The company offers commercial products including ultrasound contrast agent and medical radiopharmaceuticals in a range of imaging modalities. Its products include DEFINITY, TechneLite, Xenon 133, Neurolite, , Thallium-201, Cardiolite and Gallium-67. Its product pipeline include 1095 and...
-
Product Insights
Ra Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Ra Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Ra Medical Systems Inc (Ra Medical Systems) is a medical device company. It develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its products portfolio include dabra system a versatile catheter and excimer laser system for the treatment of complex and diffuse arterial...
-
Product Insights
Net Present Value Model: Ezogabine IR
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Ezogabine IR Drug Details Ezogabine is...
-
Product Insights
Net Present Value Model: XEN-1101
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model XEN-1101 Drug Details XEN-1101 (1OP-2198) is...
-
Track & Monitor
Innovation in Pharmaceuticals: Pyridine derivatives
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...